PULMONARY LYMPHOMATOID GRANULOMATOSIS

PULMONARY LYMPHOMATOID GRANULOMATOSIS was reported 21 times

PULMONARY LYMPHOMATOID GRANULOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Purine Antimetabolite [EPC] 7 0.0001
1 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
2 Alkylating Drug [EPC] 6 0.0000
3 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
5 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
6 Corticosteroid [EPC] 7 0.0000
7 Opioid Agonist [EPC] 1 0.0000
8 Vitamin D [EPC] 1 0.0000
9 Vitamin B12 [EPC] 1 0.0000
10 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
11 Vitamin C [EPC] 1 0.0000
12 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000